Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

PEG-rHuMGDF protects against toxicity of chemo- and radiotherapy in mice

June 12, 1998

NexMed begins clinical trials of female sexual dysfunction product

June 11, 1998

JTT-501, a novel treatment for NIDDM

June 11, 1998

Novo Nordisk and Aradigm to develop pulmonary insulin delivery system

June 11, 1998

Rosiglitazone and troglitazone exert differential effects on small arteries in vitro

June 10, 1998

Ribozyme obtains license to sickle cell anemia treatment technology

June 10, 1998

Ergo Science meets with FDA regarding Ergoset

June 10, 1998

U.K. launch of Zoladex for assisted conception

June 9, 1998

Large U.S. trial confirms high efficacy rate of mifepristone + misoprostol in early pregnancy

June 9, 1998

Hemosol advances blood substitute in clinical studies for several indications

June 9, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 5, 2026.
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 3, 2026
Slate Medicines launches with focus on headache disorders
BioWorld Science
Slate Medicines Inc. has launched with $130 million in series A financing and a focus on advancing next-generation therapeutics for migraine and other headache...